Literature DB >> 3825868

Sudden death risk in overt coronary heart disease: the Framingham Study.

W B Kannel, L A Cupples, R B D'Agostino.   

Abstract

Over 30 years of surveillance of 5127 subjects free of CHD, 760 men and 574 women developed overt CHD, and there were 160 sudden deaths in men and 73 in women. Among those who sustained clinically manifest CHD, the sudden death risk was increased 6.7 times that of those without an interim event. Although the relative risk was comparable in the two sexes, CHD did not eliminate the female advantage over men. Myocardial infarction imposed a greater sudden death risk than angina pectoris, and silent infarctions were as dangerous as symptomatic infarctions. Onset of CHD put young and old at equal risk of sudden death. Some 40% of sudden deaths occurred in the 4% of the general population with overt CHD. The proportion of coronary attacks presenting as sudden death increased from 13% at ages 35 to 64 years to 20% at ages 65 to 94 years. The fraction of CHD deaths classified as sudden deaths was lower in those with than without interim CHD. In those with established CHD, factors reflecting ischemic myocardial damage and cardiac failure were the chief predictors of sudden death. The proportion of CHD deaths presenting as sudden deaths has not declined in subjects with prior CHD over three decades, despite a national decline in the overall CHD mortality rate.

Entities:  

Mesh:

Year:  1987        PMID: 3825868     DOI: 10.1016/0002-8703(87)90722-8

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  36 in total

Review 1.  Epidemiology, diagnosis, and management of cardiac disease in chronic renal disease.

Authors:  M J Sarnak; A S Levey
Journal:  J Thromb Thrombolysis       Date:  2000-10       Impact factor: 2.300

2.  Sudden death after spontaneous ventricular fibrillation: case reports.

Authors:  H J Bethell
Journal:  J R Coll Gen Pract       Date:  1989-04

3.  Epidemiology and genetics of sudden cardiac death.

Authors:  Rajat Deo; Christine M Albert
Journal:  Circulation       Date:  2012-01-31       Impact factor: 29.690

4.  Electromechanical and structural alterations in the aging rabbit heart and aorta.

Authors:  Leroy L Cooper; Katja E Odening; Min-Sig Hwang; Leonard Chaves; Lorraine Schofield; Chantel A Taylor; Anthony S Gemignani; Gary F Mitchell; John R Forder; Bum-Rak Choi; Gideon Koren
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-02-03       Impact factor: 4.733

5.  Identification of novel missense mutations of cardiac ryanodine receptor gene in exercise-induced sudden death at autopsy.

Authors:  Wendy Creighton; Renu Virmani; Robert Kutys; Allen Burke
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

6.  C-reactive protein is associated with heart rate variability.

Authors:  Trine Madsen; Jeppe Hagstrup Christensen; Egon Toft; Erik Berg Schmidt
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-07       Impact factor: 1.468

Review 7.  Epidemiology of sudden cardiac death: clinical and research implications.

Authors:  Sumeet S Chugh; Kyndaron Reinier; Carmen Teodorescu; Audrey Evanado; Elizabeth Kehr; Mershed Al Samara; Ronald Mariani; Karen Gunson; Jonathan Jui
Journal:  Prog Cardiovasc Dis       Date:  2008 Nov-Dec       Impact factor: 8.194

Review 8.  Risk-benefit assessment of antiarrhythmic drugs. An epidemiological perspective.

Authors:  L Friedman; E Schron; S Yusuf
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

9.  Heart failure management in dialysis patients: Many treatment options with no clear evidence.

Authors:  Bethany Roehm; Gaurav Gulati; Daniel E Weiner
Journal:  Semin Dial       Date:  2020-04-13       Impact factor: 3.455

10.  Redox modification of ryanodine receptors by mitochondria-derived reactive oxygen species contributes to aberrant Ca2+ handling in ageing rabbit hearts.

Authors:  Leroy L Cooper; Weiyan Li; Yichun Lu; Jason Centracchio; Radmila Terentyeva; Gideon Koren; Dmitry Terentyev
Journal:  J Physiol       Date:  2013-09-16       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.